BridgeMD
New treatment option for Pulmonary Arterial Hypertension
Official title Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension
ClinicalTrials.gov ID: NCT07366879
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if an exercise programme started shortly after diagnosis improves the fitness and mental wellbeing of patients with pulmonary hypertenion over and above medication alone. It will also learn about whether extra support can help patients keep up with exercise in the long term.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18-years-old and above
- Diagnosed with pulmonary hypertension (group I and non-operable group IV) by right heart catheterisation showing:
- a baseline mean pulmonary artery pressure \>20mmHg
- pulmonary vascular resistance \>2 Wood Units
- pulmonary capillary wedge pressure \<15mmHg
You likely can't join if
- Diagnosis with pulmonary hypertension of any other cause
- Group II (PH due to left heart disease)
- Group III (PH due to hypoxic lung disease)
- Operable group IV (PH due to chronic thromboembolic disease amenable to surgical treatment)
- Group V (unclear and/or multifactorial elements).
- Planned treatment with a research trial medication during the study timeframe
See the full eligibility criteria
- Aged 18-years-old and above
- Diagnosed with pulmonary hypertension (group I and non-operable group IV) by right heart catheterisation showing:
- a baseline mean pulmonary artery pressure \>20mmHg
- pulmonary vascular resistance \>2 Wood Units
- pulmonary capillary wedge pressure \<15mmHg
- Able to provide written informed consent
- Diagnosis with pulmonary hypertension of any other cause
- Group II (PH due to left heart disease)
- Group III (PH due to hypoxic lung disease)
- Operable group IV (PH due to chronic thromboembolic disease amenable to surgical treatment)
- Group V (unclear and/or multifactorial elements).
- Planned treatment with a research trial medication during the study timeframe
- Consenting clinician and/or patient concern regarding the patient's safety in performing a home-based exercise programme
- Patients with syncopal episodes felt to be related to pulmonary hypertension at time of exercise intervention initiation.
- Severe concurrent medical condition that would prevent participation in study procedures
- Life expectancy \<3 months
The study team makes the final eligibility decision.
Where it's taking place
- Glasgow, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glasgow, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.